151 related articles for article (PubMed ID: 7464515)
1. [Drug therapy of poorly responding tumors in the metastatic stage].
Gremmel H; Liffers R
Med Welt; 1980 Oct; 31(43):1554-6. PubMed ID: 7464515
[No Abstract] [Full Text] [Related]
2. [Cytostatic therapy of metastasizing cancers: therapeutic indications and limitations (author's transl)].
Huber H; Denz H; Kratzer H
Wien Klin Wochenschr; 1977 Apr; 89(7):209-15. PubMed ID: 324137
[TBL] [Abstract][Full Text] [Related]
3. [The practitioner and indications for anticancerous chemotherapy].
Pestel M
Presse Med (1893); 1968 Jun; 76(27):1346-8. PubMed ID: 4301961
[No Abstract] [Full Text] [Related]
4. [Prospects of systemic drug treatment in metastasized bladder and kidney tumors].
Hartlapp JH; Illiger HJ
MMW Munch Med Wochenschr; 1983 Mar; 125(9):172-5. PubMed ID: 6405255
[No Abstract] [Full Text] [Related]
5. [Results of drug therapy of metastasis of carcinoma of the kidney].
Barsel' VA; Khaimchaev IaS
Urol Nefrol (Mosk); 1977; (1):41-3. PubMed ID: 841765
[No Abstract] [Full Text] [Related]
6. [Combined adriamycin and 5-fluorouracil therapy in the treatment of advanced cancer of the bladder (author's transl)].
Marcuello Gaspar E; Germá Lluch JR; Dorca Ribugent J; López Pousa A; Español Llorens J; Abad Esteve A; Avella Mestre A
Med Clin (Barc); 1982 Jul 1-31; 79(3):107-9. PubMed ID: 7109765
[No Abstract] [Full Text] [Related]
7. Phase II trial of amsacrine (AMSA) in urinary bladder cancer.
Natale RB; Yagoda A; Blumenreich MS; Watson RC
Cancer Treat Rep; 1983 Apr; 67(4):391-2. PubMed ID: 6687836
[No Abstract] [Full Text] [Related]
8. [Medical treatment of some solid tumors].
Lattanzi A
Clin Ter; 1979 Jan; 88(2):113-38. PubMed ID: 371905
[No Abstract] [Full Text] [Related]
9. Treatment of metastatic renal cell carcinoma: review of experience and world literature.
Luderer RC; Opipari MI; Perrotta AL
J Am Osteopath Assoc; 1978 Apr; 77(8):590-603. PubMed ID: 649445
[No Abstract] [Full Text] [Related]
10. [Systemic chemotherapy in bladder tumors].
Revol M; Schaerer R; Faure G; Delannoy P; Bodin J
J Urol Nephrol (Paris); 1974; 80(7-8):680-4. PubMed ID: 4140925
[No Abstract] [Full Text] [Related]
11. Chemotherapy of urologic neoplasms.
Koven BJ
J Med Soc N J; 1970 Oct; 67(10):617-20. PubMed ID: 5273709
[No Abstract] [Full Text] [Related]
12. [Drug therapy in metastasis of kidney neoplasms].
Matveev BM
Urol Nefrol (Mosk); 1978; (3):67-70. PubMed ID: 664128
[No Abstract] [Full Text] [Related]
13. [Role of multi-drug resistance in genito-urinary tumors].
Theyer G; Hamilton G
Prog Urol; 1993 Jun; 3(3):385-92; discussion 392-3. PubMed ID: 8103698
[No Abstract] [Full Text] [Related]
14. [Antiblastic chemotherapy in urology].
Furnari S; Pavone-Macaluso S; Veroux G; Mattea E
Minerva Urol; 1971; 23(2):87-9. PubMed ID: 5105988
[No Abstract] [Full Text] [Related]
15. Prognostic factors for metastatic urothelial carcinoma treated with cisplatin and 5-fluorouracil-based regimens.
Lin CC; Hsu CH; Huang CY; Tsai YC; Huang KH; Cheng AL; Pu YS
Urology; 2007 Mar; 69(3):479-84. PubMed ID: 17382149
[TBL] [Abstract][Full Text] [Related]
16. The current status of cancer chemotherapy for selected human neoplasms.
Rubin RN
Clin Ther; 1981; 4(2):74-94. PubMed ID: 7028265
[No Abstract] [Full Text] [Related]
17. [Chemotherapy of neuroblastomas].
Fedi B; Di Silverio F; Coppola R
Cancro; 1969; 22(5):483-502. PubMed ID: 5401720
[No Abstract] [Full Text] [Related]
18. [Current chemotherapy of locally advanced or metastatic bladder tumors].
Dourthe LM; Ceccaldi B; Fournier R; Houlgatte A; Merrer J
Ann Urol (Paris); 2000 Feb; 34(1):3-8. PubMed ID: 10763417
[TBL] [Abstract][Full Text] [Related]
19. [Therapy of urinary bladder tumors].
Rabkova LM
Vopr Onkol; 1967; 13(9):52-8. PubMed ID: 4971095
[No Abstract] [Full Text] [Related]
20. [Cytostatic adjuvant therapy of tumors in the urogenital region].
Vahlensieck W
Haematol Blood Transfus; 1978; 22():165-74. PubMed ID: 220154
[No Abstract] [Full Text] [Related]
[Next] [New Search]